Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for MRVI

Stock NameMaravai Lifesciences Holdings Inc
TickerMRVI(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS56600D1072

Show aggregate MRVI holdings

News associated with MRVI

Friday's ETF Movers: URA, FIG
In trading on Friday, the Uranium ETF is outperforming other ETFs, up about 5% on the day. Components of that ETF showing particular strength include shares of Centrus Energy, up about 10.8% and shares of F3 Uranium, up about 8.1% on the day. And underperforming other ETFs tod - 2025-09-19 13:06:00
Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading on Wednesday. Traders purchased 1,002 put options on the stock. This is an increase of approximately 1,791% compared to the average daily volume of 53 put options. Institutional Investors Weigh In On Maravai LifeSciences Several institutional investors have recently modified their […] - 2025-09-18 04:28:53
Stock Traders Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the target of some unusual options trading on Wednesday. Stock traders purchased 1,002 put options on the company. Thisrepresentsanincreaseof1,791% compared to the average volume of 53 put options. Analyst Ratings Changes Several research analysts recently commented on MRVI shares. Craig Hallum reduced their target price […] - 2025-08-21 05:04:47
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have been given a consensus recommendation of “Hold” by the twelve ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and four have assigned a […] - 2025-07-30 02:46:50
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Investors purchased 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the average volume of 53 put options. Maravai LifeSciences Trading Up 3.6% Shares of NASDAQ:MRVI opened at $2.62 […] - 2025-07-24 04:57:04
Investors Purchase High Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading activity on Wednesday. Traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the typical volume of 53 put options. Maravai LifeSciences Price Performance Maravai LifeSciences stock opened at $2.76 on Thursday. The stock has […] - 2025-07-10 04:17:04
SG Americas Securities LLC Purchases 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
SG Americas Securities LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 2,005.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 695,907 shares of the company’s stock after purchasing an additional 662,861 shares during the quarter. SG […] - 2025-06-16 04:54:59
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $6.64 Average PT from Analysts
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have received an average recommendation of “Hold” from the twelve analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and four have issued a buy recommendation on […] - 2025-06-13 02:32:51
Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading activity on Wednesday. Stock traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the average daily volume of 53 put options. Maravai LifeSciences Trading Up 5.6% Shares of MRVI opened at $2.28 on Thursday. […] - 2025-06-12 04:44:46
Traders Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) saw unusually large options trading activity on Wednesday. Traders bought 1,002 put options on the company. This represents an increase of 1,791% compared to the typical volume of 53 put options. Hedge Funds Weigh In On Maravai LifeSciences A number of hedge funds have recently added […] - 2025-05-30 05:39:03
Ameriprise Financial Inc. Raises Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Ameriprise Financial Inc. lifted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,611,625 shares of the company’s stock after purchasing an additional 62,123 shares during the quarter. Ameriprise Financial Inc. owned […] - 2025-05-16 05:03:26
Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Price T Rowe Associates Inc. MD lifted its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 12.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 70,828 shares of the company’s stock after purchasing an additional 7,946 shares during the […] - 2025-05-15 05:20:51
Dimensional Fund Advisors LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Dimensional Fund Advisors LP grew its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 20.4% during the fourth quarter, Holdings Channel reports. The firm owned 1,311,700 shares of the company’s stock after purchasing an additional 221,908 shares during the period. Dimensional Fund Advisors LP’s holdings in Maravai LifeSciences were worth […] - 2025-05-12 04:47:02
Envestnet Asset Management Inc. Has $104,000 Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Envestnet Asset Management Inc. lowered its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 55.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 19,016 shares of the company’s stock after selling 23,677 shares during the period. Envestnet Asset Management Inc.’s holdings in Maravai LifeSciences were worth $104,000 as […] - 2025-05-09 04:22:43
Barclays PLC Purchases 23,103 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Barclays PLC boosted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 12.5% in the fourth quarter, Holdings Channel reports. The fund owned 207,292 shares of the company’s stock after purchasing an additional 23,103 shares during the quarter. Barclays PLC’s holdings in Maravai LifeSciences were worth $1,129,000 as of its […] - 2025-05-05 04:48:49
Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This is an increase of 1,791% compared to the typical volume of 53 put options. Wall Street Analysts Forecast Growth A number of research firms recently weighed in […] - 2025-05-01 04:47:03
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $6.34 Consensus PT from Analysts
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have issued a buy recommendation on the […] - 2025-04-24 02:28:50
Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Investors purchased 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the average volume of 53 put options. Maravai LifeSciences Stock Performance NASDAQ MRVI opened at $1.72 on Thursday. […] - 2025-04-17 04:40:59
JPMorgan Chase & Co. Purchases 200,411 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
JPMorgan Chase & Co. grew its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 4.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 4,250,656 shares of the company’s stock after acquiring an additional 200,411 shares during the period. JPMorgan Chase & Co.’s […] - 2025-04-10 05:07:14
Orion Portfolio Solutions LLC Sells 39,057 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Orion Portfolio Solutions LLC decreased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 28.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 96,692 shares of the company’s stock after selling 39,057 shares during the period. Orion Portfolio Solutions LLC’s holdings in Maravai LifeSciences […] - 2025-04-08 04:58:52
Mitsubishi UFJ Asset Management Co. Ltd. Grows Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 118.5% in the fourth quarter, HoldingsChannel reports. The firm owned 52,508 shares of the company’s stock after buying an additional 28,480 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Maravai LifeSciences were […] - 2025-04-04 05:12:56
10,336 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Cibc World Markets Corp
Cibc World Markets Corp purchased a new stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 10,336 shares of the company’s stock, valued at approximately $56,000. A number of other institutional investors and hedge funds […] - 2025-03-28 06:18:49
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of “Hold” by Brokerages
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and four have given a buy recommendation to the […] - 2025-03-27 04:38:49
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Short Interest Update
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of a large decline in short interest in February. As of February 28th, there was short interest totalling 8,820,000 shares, a decline of 14.4% from the February 13th total of 10,300,000 shares. Based on an average daily volume of 2,640,000 shares, the short-interest […] - 2025-03-21 05:10:51
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders acquired 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the typical volume of 53 put options. Insider Transactions at Maravai LifeSciences In other news, General Counsel Kurt Oreshack […] - 2025-03-20 06:14:54
Rhumbline Advisers Has $1.01 Million Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Rhumbline Advisers raised its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 9.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 185,221 shares of the company’s stock after buying an additional 16,712 shares during the period. Rhumbline Advisers’ holdings in Maravai LifeSciences were worth $1,009,000 at the end of the […] - 2025-03-07 06:22:56
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This represents an increase of 1,791% compared to the typical daily volume of 53 put options. Insider Activity at Maravai LifeSciences In related news, General Counsel Kurt Oreshack […] - 2025-03-06 05:03:00
Maravai LifeSciences (NASDAQ:MRVI) Hits New 12-Month Low Following Analyst Downgrade
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00. Bank of America currently has a buy rating on the stock. Maravai LifeSciences traded as low as $2.92 and last traded at […] - 2025-03-06 04:29:07
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 6.7% on Analyst Downgrade
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price was down 6.7% during trading on Monday after Bank of America lowered their price target on the stock from $9.00 to $8.00. Bank of America currently has a buy rating on the stock. Maravai LifeSciences traded as low as $3.01 and last traded at […] - 2025-03-05 04:53:09
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives $9.46 Consensus Price Target from Brokerages
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has been assigned an average recommendation of “Hold” from the twelve brokerages that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the […] - 2025-03-05 04:20:49

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) MRVI holdings

DateNumber of MRVI Shares HeldBase Market Value of MRVI SharesLocal Market Value of MRVI SharesChange in MRVI Shares HeldChange in MRVI Base ValueCurrent Price per MRVI Share HeldPrevious Price per MRVI Share Held
2025-11-11 (Tuesday)100,364USD 326,183USD 326,183
2025-11-10 (Monday)100,364MRVI holding increased by 262USD 311,128MRVI holding increased by 23835USD 311,128262USD 23,835 USD 3.1 USD 2.87
2025-11-07 (Friday)100,102USD 287,293MRVI holding decreased by -2002USD 287,2930USD -2,002 USD 2.87 USD 2.89
2025-11-06 (Thursday)100,102MRVI holding increased by 262USD 289,295MRVI holding increased by 2754USD 289,295262USD 2,754 USD 2.89 USD 2.87
2025-11-05 (Wednesday)99,840USD 286,541USD 286,5410USD 0 USD 2.87 USD 2.87
2025-11-04 (Tuesday)99,840MRVI holding increased by 264USD 286,541MRVI holding decreased by -6212USD 286,541264USD -6,212 USD 2.87 USD 2.94
2025-11-03 (Monday)99,576USD 292,753MRVI holding decreased by -19916USD 292,7530USD -19,916 USD 2.94 USD 3.14
2025-10-31 (Friday)99,576USD 312,669USD 312,6690USD 0 USD 3.14 USD 3.14
2025-10-30 (Thursday)99,576MRVI holding increased by 1320USD 312,669MRVI holding increased by 11023USD 312,6691,320USD 11,023 USD 3.14 USD 3.07
2025-10-29 (Wednesday)98,256MRVI holding increased by 526USD 301,646MRVI holding decreased by -14022USD 301,646526USD -14,022 USD 3.07 USD 3.23
2025-10-28 (Tuesday)97,730USD 315,668MRVI holding decreased by -10750USD 315,6680USD -10,750 USD 3.23 USD 3.34
2025-10-27 (Monday)97,730USD 326,418MRVI holding decreased by -6841USD 326,4180USD -6,841 USD 3.34 USD 3.41
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRVI by Blackrock for IE00BYXG2H39

Show aggregate share trades of MRVI

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY2623.1852.800 2.838USD 744 3.40
2025-11-06BUY2622.9502.810 2.824USD 740 3.41
2025-11-04BUY2642.9552.860 2.869USD 758 3.41
2025-10-30BUY1,3203.1753.010 3.026USD 3,995 3.42
2025-10-29BUY5263.0703.270 3.250USD 1,709 3.42
2025-10-22SELL-1,0443.4103.450 3.446USD -3,598 3.42 Loss of -25 on sale
2025-10-20BUY5223.5203.570 3.565USD 1,861 3.42
2025-10-17BUY1,3023.3003.520 3.498USD 4,554 3.42
2025-10-15BUY2,0643.3703.375 3.374USD 6,965 3.42
2025-10-03BUY1,8553.0903.300 3.279USD 6,083 3.43
2025-10-02BUY2642.9703.210 3.186USD 841 3.43
2025-09-30BUY5302.8702.880 2.879USD 1,526 3.43
2025-09-26BUY5302.8202.840 2.838USD 1,504 3.44
2025-09-25BUY5302.6902.750 2.744USD 1,454 3.44
2025-09-24BUY12.7202.790 2.783USD 3 3.45
2025-09-18BUY2672.8802.925 2.920USD 780 3.45
2025-09-17BUY8042.8102.975 2.958USD 2,379 3.46
2025-08-20SELL-1,0562.4602.560 2.550USD -2,693 3.48 Profit of 980 on sale
2025-07-30BUY1,0402.4102.570 2.554USD 2,656 3.51
2025-07-17SELL-5222.5102.600 2.591USD -1,353 3.57 Profit of 511 on sale
2025-07-11SELL-2,1042.7302.850 2.838USD -5,971 3.60 Profit of 1,593 on sale
2025-07-07BUY7922.6002.709 2.698USD 2,137 3.62
2025-07-02BUY14,5202.6502.720 2.713USD 39,393 3.63
2025-06-11BUY5342.2802.345 2.339USD 1,249 3.72
2025-06-10BUY5342.1602.365 2.345USD 1,252 3.73
2025-06-04SELL-2672.2102.300 2.291USD -612 3.78 Profit of 398 on sale
2025-04-23BUY2672.1002.205 2.194USD 586 4.29
2025-04-10SELL-2,1281.7801.870 1.861USD -3,960 4.54 Profit of 5,699 on sale
2025-04-08SELL-2661.8802.080 2.060USD -548 4.60 Profit of 675 on sale
2025-04-07SELL-2661.9902.150 2.134USD -568 4.63 Profit of 664 on sale
2025-04-04SELL-1,3401.9402.085 2.071USD -2,774 4.66 Profit of 3,472 on sale
2025-04-01BUY11,2652.1602.250 2.241USD 25,245 4.72
2025-03-31SELL-6962.2102.340 2.327USD -1,620 4.75 Profit of 1,688 on sale
2025-03-14SELL-3,7282.4502.535 2.527USD -9,419 5.12 Profit of 9,654 on sale
2025-03-07SELL-4662.9603.055 3.046USD -1,419 5.30 Profit of 1,050 on sale
2025-03-04SELL-2332.8402.970 2.957USD -689 5.42 Profit of 574 on sale
2025-02-25BUY4643.1403.556 3.514USD 1,631 5.62
2025-02-19SELL-2304.0804.220 4.206USD -967 5.73 Profit of 351 on sale
2025-02-13BUY6844.1204.315 4.296USD 2,938 5.86
2025-02-12BUY2284.2604.370 4.359USD 994 5.89
2025-02-11BUY9124.2404.360 4.348USD 3,965 5.93
2024-12-30SELL-7,6655.5105.610 5.600USD -42,924 6.29 Profit of 5,305 on sale
2024-11-18SELL-3,6934.5504.650 4.640USD -17,136 7.31 Profit of 9,866 on sale
2024-11-12SELL-2455.7005.880 5.862USD -1,436 7.42 Profit of 381 on sale
2024-10-21SELL-2478.5008.520 8.518USD -2,104 0.00 Loss of -2,104 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRVI

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19286,4264,675472,52160.6%
2025-09-18146,3421,400344,80342.4%
2025-09-17128,4060293,85143.7%
2025-09-16191,1450395,45448.3%
2025-09-15194,845100379,83551.3%
2025-09-12373,3530605,26061.7%
2025-09-11235,739511414,77656.8%
2025-09-10451,2540556,86081.0%
2025-09-09541,7150749,11472.3%
2025-09-08222,0610391,89956.7%
2025-09-05148,3671,000419,17935.4%
2025-09-04121,3320193,89462.6%
2025-09-03192,060148233,59382.2%
2025-09-02257,2210410,85962.6%
2025-08-29130,6030210,42062.1%
2025-08-28146,286683271,81653.8%
2025-08-27251,8310380,18766.2%
2025-08-26108,3560222,86848.6%
2025-08-25205,979100302,25368.1%
2025-08-22140,3590300,81146.7%
2025-08-21109,5610203,55753.8%
2025-08-20186,8340339,79655.0%
2025-08-19138,3431,467309,03044.8%
2025-08-18320,8131,580587,15554.6%
2025-08-15179,3240280,90063.8%
2025-08-14167,34311316,81152.8%
2025-08-13243,201179541,07344.9%
2025-08-12953,1037,4192,040,73546.7%
2025-08-11228,9070492,63646.5%
2025-08-08261,1891,016536,24648.7%
2025-08-07548,63314,8001,538,92735.7%
2025-08-06497,39619,740803,11061.9%
2025-08-05363,2560482,29775.3%
2025-08-04366,8700715,83151.3%
2025-08-01402,4960485,11183.0%
2025-07-31327,9610499,01465.7%
2025-07-30226,7400345,52765.6%
2025-07-29248,45710493,08050.4%
2025-07-28418,11866547,61976.4%
2025-07-25253,0331,703315,35080.2%
2025-07-24333,273164543,84961.3%
2025-07-23286,5771,202482,10759.4%
2025-07-22224,843105420,66553.4%
2025-07-21925,1021,5001,060,64287.2%
2025-07-18400,7367,109626,68363.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.